Sign in
4

Changes in Ownership

ORAMED PHARMACEUTICALS INC. Filed Acc 0001209191-23-018952

Chief Scientific Officer sold 100,000 shares at $2.01 ($201,000)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kidron Miriam Chief Scientific Officer 2023-03-14 Sale −100,000 $2.01 $201,000 201,666 D
Open-market sales · 100,000 sh · avg $2.01 · $201,000
Loading xslF345X03/doc4.xml…